| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 57,312 | 61,699 | 67,097 | 65,080 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 61,699 | 67,097 | 65,080 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,536 | 52,056 | 61,749 | 59,891 | | Non Recurring | (381) | 64,393 | (67) | 5,089 | | Others | 20,307 | 531 | 455 | 455 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,850 | (55,281) | 4,960 | (355) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 3,850 | (55,281) | 4,960 | (355) | | Interest Expense | 989 | 979 | 969 | 1,033 | | Income Before Tax | 2,861 | (56,260) | 3,991 | (1,388) | | Income Tax Expense | 101 | 15,272 | 1,597 | (385) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,760 | (71,532) | 2,394 | (1,003) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,760 | (71,532) | 2,394 | (1,003) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,760 | ($71,532) | $2,394 | ($1,003) |
|
0.51% Nasdaq 
Income Statement
